It is important to understand the differences between risk-based decision making and other decision making in a pharmaceutical quality system.

No­vo Nordisk is con­tin­u­ing its cit­i­zen pe­ti­tion cru­sade at the FDA, this time aim­ing to stop the com­pound­ing of Vic­toza, its block­buster GLP-1.

To hear Novo tell it, the outsourcing group OFA shouldn’t be allowed to place liraglutide on its compounding list given that FDA-approved generics to Victoza are available. Further, the OFA has ...

The FDA approved Hikma's first generic referencing Victoza (liraglutide injection) 18 milligram/3 milliliter, a glucagon-like peptide-1 (GLP-1) receptor agonist indicated to improve glycemic ...

Once there, he received 10 vials of antivenom, however, the swelling on his shin continued to increase. At first, the pain was so bad that he didn’t think it was the result of a snake bite.

Liraglutide (Victoza) is a potent anti-diabetic agent ... glucagon hypokit; cartridge; needles; vials; insulin; estradiol for hormone replacement; recombinant drugs for haemophilia; glucagon; and oral ...